Dow Up 0.22% Nasdaq Up 0.31%

Vertex Pharmaceuticals Incorporated (VRTX)

-NasdaqGS
117.88 Up 2.49(2.16%) 12:15PM EST - Nasdaq Real Time Price
Prev Close:115.39
Open:115.65
Bid:118.22 x 100
Ask:118.28 x 100
1y Target Est:122.05
Beta:-0.75
Earnings Date:Jan 27 - Feb 2 (Est.)
Day's Range:115.65 - 120.90
52wk Range:59.79 - 120.90
Volume:744,383
Avg Vol (3m):1,663,940
Market Cap:28.35B
P/E (ttm):N/A
EPS (ttm):-2.22
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
VRTXUp 2.16%28.35B
BMYUp 0.46%98.08B
MRKUp 1.47%172.85B
PTCTUp 1.52%1.34B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):35.26
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-2.99
Quarterly EPS Est (Dec-14) :-0.65
Mean Recommendation*:2.1
PEG Ratio (5 yr expected):-2.03

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Vertex Pharmaceuticals Incorporated is engaged in discovering, developing, manufacturing, and commercializing small molecule drugs for patients with serious diseases in specialty markets. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback